Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus
- 1 December 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (12) , 2733-2737
- https://doi.org/10.1128/aac.41.12.2733
Abstract
Fluoroquinolone resistance in Staphylococcus aureus results from amino acid substitutions at particular locations in the DNA gyrase A and B subunits as well as in the topoisomerase IV A subunit and from NorA-mediated efflux. More than one resistance mechanism may be present in a single strain. Fluoroquinolone-resistant derivatives of SA-1199, a methicillin-susceptible S. aureus strain, were selected in vivo or in vitro, and their mechanisms of fluoroquinolone resistance were identified. We found that many of the resistance mechanisms described above can develop in derivatives of a single parent strain, either singly or in combination, and can arise in a single step. Variances in MICs for strains with the same apparent resistance mechanisms likely are due to the presence of new or undetected but established means of fluoroquinolone resistance. NorA-mediated resistance can occur in the apparent absence of topoisomerase mutations and in some strains may be the result of a promoter region mutation causing increased expression of norA. However, increased expression of norA can occur independently of this mutation, suggesting that a regulatory locus for this gene exists elsewhere on the chromosome.Keywords
This publication has 21 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1995
- Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1995
- Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1994
- Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolonesMolecular Microbiology, 1994
- Efflux-mediated fluoroquinolone resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporterAntimicrobial Agents and Chemotherapy, 1993
- Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencingAntimicrobial Agents and Chemotherapy, 1992
- Mechanisms of Fluoroquinolone Resistance in Staphylococcus aureusThe Journal of Infectious Diseases, 1991